- Corporate Officers - G
- Goldberg Mark Alan
Insider Trading History of Goldberg Mark Alan
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Goldberg Mark Alan since 2012.
This trader's CIK number is 1532475.
At the time of last reporting, Goldberg Mark Alan was the Officer of Immunogen, Inc.. (stock ticker symbol IMGN).
Also see all insider trading activities at Immunogen, Inc..
Note that in the past
Goldberg Mark Alan also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Glycomimetics Inc (GLYC) by Goldberg Mark Alan
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | GLYC | 10,397 | $49,635 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Trimeris Inc (GEVA) by Goldberg Mark Alan
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | GEVA | 0 | $0 | 35,966 | $2,662,279 | 35,966 | $201,958 |
2013 | GEVA | 0 | $0 | 34,250 | $1,903,171 | 34,250 | $195,917 |
Yearly summary of insider trading at Aceragen, Inc. (IDRA) by Goldberg Mark Alan
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | IDRA | 10,000 | $31,900 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Immunogen, Inc. (IMGN) by Goldberg Mark Alan
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | IMGN | 0 | $0 | 0 | $0 | 20,000 | $297,800 |
2018 | IMGN | 30,000 | $172,800 | 0 | $0 | 0 | $0 |
2016 | IMGN | 20,000 | $36,000 | 0 | $0 | 0 | $0 |
2012 | IMGN | 3,000 | $33,804 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Blueprint Medicines Corp (BPMC) by Goldberg Mark Alan
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | BPMC | 5,000 | $299,900 | 0 | $0 | 0 | $0 |
2020 | BPMC | 0 | $0 | 32,727 | $3,681,795 | 34,039 | $827,228 |
Insider trading activities at 5 companies by Goldberg Mark Alan:
1. Glycomimetics Inc (GLYC)
2. Trimeris Inc (GEVA)
3. Aceragen, Inc. (IDRA)
4. Immunogen, Inc. (IMGN)
5. Blueprint Medicines Corp (BPMC)
Table 1. Insider trading of Glycomimetics Inc (GLYC) by Goldberg Mark Alan
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-03-04 | GLYC | Buy | 10,397 | 4.77 | 49,635 |
Table 2. Insider trading of Trimeris Inc (GEVA) by Goldberg Mark Alan
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-09-19 | GEVA | Option Ex | 790 | 8.73 | 6,896 |
2014-09-19 | GEVA | Sale | 790 | 65.24 | 51,539 |
2014-09-16 | GEVA | Option Ex | 9,379 | 8.73 | 81,878 |
2014-09-17 | GEVA | Option Ex | 4,200 | 8.73 | 36,666 |
2014-09-16 | GEVA | Sale | 9,379 | 65.01 | 609,728 |
2014-09-17 | GEVA | Sale | 4,200 | 65.06 | 273,252 |
2014-06-11 | GEVA | Option Ex | 21,597 | 3.54 | 76,518 |
2014-06-11 | GEVA | Sale | 21,597 | 80.00 | 1,727,760 |
2013-12-02 | GEVA | Option Ex | 7,000 | 8.73 | 61,110 |
2013-12-03 | GEVA | Sale | 7,000 | 60.76 | 425,285 |
2013-11-01 | GEVA | Sale | 7,000 | 50.33 | 352,310 |
2013-11-01 | GEVA | Option Ex | 7,000 | 8.73 | 61,110 |
2013-10-01 | GEVA | Option Ex | 7,000 | 8.73 | 61,110 |
2013-10-01 | GEVA | Sale | 7,000 | 64.29 | 450,030 |
2013-04-01 | GEVA | Option Ex | 4,416 | .95 | 4,195 |
2013-04-01 | GEVA | Sale | 4,416 | 54.56 | 240,959 |
2013-03-01 | GEVA | Sale | 4,417 | 50.87 | 224,692 |
2013-03-01 | GEVA | Option Ex | 4,417 | .95 | 4,196 |
2013-01-02 | GEVA | Sale | 4,417 | 47.52 | 209,895 |
2013-01-02 | GEVA | Option Ex | 4,417 | .95 | 4,196 |
Table 3. Insider trading of Aceragen, Inc. (IDRA) by Goldberg Mark Alan
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-12-19 | IDRA | Buy | 10,000 | 3.19 | 31,900 |
Table 4. Insider trading of Immunogen, Inc. (IMGN) by Goldberg Mark Alan
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-10-30 | IMGN | Option Ex | 20,000 | 14.89 | 297,800 |
2018-11-06 | IMGN | Buy | 30,000 | 5.76 | 172,800 |
2016-12-15 | IMGN | Buy | 20,000 | 1.80 | 36,000 |
2012-11-08 | IMGN | Buy | 3,000 | 11.27 | 33,804 |
Table 5. Insider trading of Blueprint Medicines Corp (BPMC) by Goldberg Mark Alan
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-03-03 | BPMC | Buy | 5,000 | 59.98 | 299,900 |
2020-12-24 | BPMC | Option Ex | 5,455 | 28.15 | 153,558 |
2020-12-24 | BPMC | Sale | 5,455 | 125.00 | 681,875 |
2020-12-18 | BPMC | Option Ex | 5,454 | 28.15 | 153,530 |
2020-12-18 | BPMC | Sale | 5,454 | 120.00 | 654,480 |
2020-12-11 | BPMC | Option Ex | 5,455 | 28.15 | 153,558 |
2020-12-11 | BPMC | Sale | 5,455 | 115.00 | 627,325 |
2020-12-01 | BPMC | Option Ex | 5,454 | 28.15 | 153,530 |
2020-12-01 | BPMC | Sale | 5,454 | 110.00 | 599,940 |
2020-10-19 | BPMC | Sale | 5,455 | 105.00 | 572,775 |
2020-10-19 | BPMC | Option Ex | 5,455 | 19.53 | 106,536 |
2020-10-07 | BPMC | Option Ex | 5,454 | 19.53 | 106,516 |
2020-10-07 | BPMC | Sale | 5,454 | 100.00 | 545,400 |
2020-06-19 | BPMC | Option Ex | 1,312 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Goldberg Mark Alan
(Officer of Immunogen, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.